Boston Scientific Corp (MIL:1BSX)
€ 85.5 0 (0%) Market Cap: 126.98 Bil Enterprise Value: 135.61 Bil PE Ratio: 74.26 PB Ratio: 6.39 GF Score: 56/100

Boston Scientific Corp at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2022 / 01:15PM GMT
Robert Justin Marcus
JPMorgan Chase & Co, Research Division - Analyst

Good Morning. I'm happy to kick off day 3 here with Boston Scientific. I'm Robbie Marcus, medtech analyst at JPMorgan. Very happy to introduce Mike Mahoney, the CEO of Boston Scientific. And afterwards in Q&A, we're going to have Dan Brennan and Lauren Tengler join us as well. But with that, Mike, I see you're in San Fran. You're ready to go.

Michael F. Mahoney
Boston Scientific Corporation - Chairman, President & CEO

I am.

Robert Justin Marcus
JPMorgan Chase & Co, Research Division - Analyst

I'll hand it off to you.

Michael F. Mahoney
Boston Scientific Corporation - Chairman, President & CEO

We're planting the flag in support of your meeting here. Well, thank you, Robbie. As you know, it's a -- we feel honored to help represent Boston Scientific at this JPMorgan conference.

For those who are less familiar with it, it's a very exciting company, very innovative, focused

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot